Annual EBITDA
-$9.19 M
+$1.31 M+12.45%
December 31, 2023
Summary
- As of February 7, 2025, SCNI annual EBITDA is -$9.19 million, with the most recent change of +$1.31 million (+12.45%) on December 31, 2023.
- During the last 3 years, SCNI annual EBITDA has fallen by -$8.91 million (-3194.62%).
- SCNI annual EBITDA is now -3194.62% below its all-time high of -$279.00 thousand, reached on December 1, 2020.
Performance
SCNI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$12.84 M
+$14.37 M+938.47%
September 1, 2024
Summary
- As of February 7, 2025, SCNI quarterly EBITDA is $12.84 million, with the most recent change of +$14.37 million (+938.47%) on September 1, 2024.
- Over the past year, SCNI quarterly EBITDA has increased by +$14.61 million (+824.44%).
- SCNI quarterly EBITDA is now -21.28% below its all-time high of $16.31 million, reached on September 1, 2020.
Performance
SCNI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$7.79 M
+$14.79 M+211.37%
September 1, 2024
Summary
- As of February 7, 2025, SCNI TTM EBITDA is $7.79 million, with the most recent change of +$14.79 million (+211.37%) on September 1, 2024.
- Over the past year, SCNI TTM EBITDA has increased by +$15.71 million (+198.47%).
- SCNI TTM EBITDA is now at all-time high.
Performance
SCNI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SCNI EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.4% | +824.4% | +198.5% |
| 3 y3 years | -3194.6% | +552.3% | +174.8% |
| 5 y5 years | +53.2% | +552.3% | +174.8% |
SCNI EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.4% | at high | +397.5% | at high | +165.5% |
| 5 y | 5-year | -3194.6% | +65.6% | -21.3% | +190.8% | at high | +130.0% |
| alltime | all time | -3194.6% | +65.6% | -21.3% | +190.8% | at high | +130.0% |
Scinai Immunotherapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $12.84 M(-938.5%) | $7.79 M(-211.4%) |
| Jun 2024 | - | -$1.53 M(-13.6%) | -$7.00 M(-11.6%) |
| Mar 2024 | - | -$1.77 M(+1.9%) | -$7.92 M(-13.9%) |
| Dec 2023 | -$9.19 M(-12.4%) | -$1.74 M(-11.1%) | -$9.19 M(-10.7%) |
| Sep 2023 | - | -$1.96 M(-20.1%) | -$10.29 M(-1.0%) |
| Jun 2023 | - | -$2.45 M(-19.7%) | -$10.40 M(-5.4%) |
| Mar 2023 | - | -$3.05 M(+7.4%) | -$10.99 M(+5.4%) |
| Dec 2022 | -$10.50 M(+1.0%) | -$2.84 M(+37.6%) | -$10.42 M(-12.4%) |
| Sep 2022 | - | -$2.06 M(-32.1%) | -$11.90 M(+2.7%) |
| Jun 2022 | - | -$3.04 M(+22.5%) | -$11.58 M(+4.4%) |
| Mar 2022 | - | -$2.48 M(-42.5%) | -$11.09 M(+7.9%) |
| Dec 2021 | -$10.39 M(+3624.4%) | - | - |
| Dec 2021 | - | -$4.31 M(+146.6%) | -$10.28 M(-25.9%) |
| Sep 2021 | - | -$1.75 M(-31.4%) | -$13.88 M(-432.6%) |
| Jun 2021 | - | -$2.55 M(+52.7%) | $4.17 M(+87.1%) |
| Mar 2021 | - | -$1.67 M(-78.9%) | $2.23 M(-23.2%) |
| Dec 2020 | -$279.00 K(-99.0%) | -$7.91 M(-148.5%) | $2.91 M(-187.6%) |
| Sep 2020 | - | $16.31 M(-463.0%) | -$3.32 M(-86.7%) |
| Jun 2020 | - | -$4.49 M(+352.2%) | -$25.01 M(-3.6%) |
| Mar 2020 | - | -$993.40 K(-93.0%) | -$25.95 M(+7.4%) |
| Dec 2019 | -$26.75 M(+36.3%) | -$14.14 M(+162.6%) | -$24.17 M(+28.2%) |
| Sep 2019 | - | -$5.38 M(-1.0%) | -$18.85 M(+34.2%) |
| Jun 2019 | - | -$5.44 M(-791.8%) | -$14.05 M(-7.4%) |
| Mar 2019 | - | $785.80 K(-108.9%) | -$15.17 M(-22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$19.63 M(+100.0%) | -$8.82 M(+1422.0%) | -$19.51 M(+7.6%) |
| Sep 2018 | - | -$579.40 K(-91.2%) | -$18.14 M(+5.8%) |
| Jun 2018 | - | -$6.56 M(+84.6%) | -$17.14 M(+51.8%) |
| Mar 2018 | - | -$3.55 M(-52.2%) | -$11.29 M(+32.6%) |
| Dec 2017 | -$9.81 M(+340.9%) | -$7.44 M(-1883.5%) | -$8.51 M(+385.4%) |
| Sep 2017 | - | $417.30 K(-158.7%) | -$1.75 M(-34.6%) |
| Jun 2017 | - | -$711.10 K(-8.3%) | -$2.68 M(+2.9%) |
| Mar 2017 | - | -$775.80 K(+13.4%) | -$2.60 M(+21.4%) |
| Dec 2016 | -$2.23 M(-18.6%) | -$684.20 K(+34.4%) | -$2.15 M(-16.1%) |
| Sep 2016 | - | -$509.00 K(-19.9%) | -$2.56 M(+29.7%) |
| Jun 2016 | - | -$635.60 K(+100.8%) | -$1.97 M(-8.1%) |
| Mar 2016 | - | -$316.60 K(-71.1%) | -$2.14 M(-4.6%) |
| Dec 2015 | -$2.73 M(+42.6%) | -$1.10 M(-1522.6%) | -$2.25 M(+41.9%) |
| Sep 2015 | - | $77.10 K(-109.5%) | -$1.58 M(-24.7%) |
| Jun 2015 | - | -$808.30 K(+92.8%) | -$2.10 M(+12.2%) |
| Mar 2015 | - | -$419.30 K(-3.3%) | -$1.87 M(-4.6%) |
| Dec 2014 | -$1.92 M(-3.7%) | -$433.70 K(-1.8%) | -$1.97 M(-5.4%) |
| Sep 2014 | - | -$441.50 K(-23.9%) | -$2.08 M(-1.9%) |
| Jun 2014 | - | -$580.30 K(+13.7%) | -$2.12 M(+37.7%) |
| Mar 2014 | - | -$510.30 K(-6.5%) | -$1.54 M(+49.7%) |
| Dec 2013 | -$1.99 M(-11.5%) | -$546.00 K(+13.4%) | -$1.03 M(+113.4%) |
| Sep 2013 | - | -$481.50 K | -$481.50 K |
| Dec 2012 | -$2.25 M(+21.8%) | - | - |
| Dec 2011 | -$1.85 M | - | - |
FAQ
- What is Scinai Immunotherapeutics annual EBITDA?
- What is the all time high annual EBITDA for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual EBITDA year-on-year change?
- What is Scinai Immunotherapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly EBITDA year-on-year change?
- What is Scinai Immunotherapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics TTM EBITDA year-on-year change?
What is Scinai Immunotherapeutics annual EBITDA?
The current annual EBITDA of SCNI is -$9.19 M
What is the all time high annual EBITDA for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual EBITDA is -$279.00 K
What is Scinai Immunotherapeutics annual EBITDA year-on-year change?
Over the past year, SCNI annual EBITDA has changed by +$1.31 M (+12.45%)
What is Scinai Immunotherapeutics quarterly EBITDA?
The current quarterly EBITDA of SCNI is $12.84 M
What is the all time high quarterly EBITDA for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly EBITDA is $16.31 M
What is Scinai Immunotherapeutics quarterly EBITDA year-on-year change?
Over the past year, SCNI quarterly EBITDA has changed by +$14.61 M (+824.44%)
What is Scinai Immunotherapeutics TTM EBITDA?
The current TTM EBITDA of SCNI is $7.79 M
What is the all time high TTM EBITDA for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high TTM EBITDA is $7.79 M
What is Scinai Immunotherapeutics TTM EBITDA year-on-year change?
Over the past year, SCNI TTM EBITDA has changed by +$15.71 M (+198.47%)